In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
NCT00771355 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2011-03-30
Summary
This is a pilot study to evaluate the findings of the Reflectance Confocal Microscopy when performed in cutaneous pigmentary disorders, such as vitiligo, melasma, post-inflammatory hyper-pigmentation and hypo-pigmentation. Confocal Microscopy is a recent diagnostic technique that has been used for observation of skin conditions that affect the superficial layers of the skin.
Conditions
- Vitiligo
- Melasma
- Hyperpigmentation
- Hypopigmentation
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Ernesto Gonzalez, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- United States
Study Locations
More Related Trials
-
Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo
NCT03158675 ·Status: UNKNOWN ·Phase: NA
-
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
NCT02506101 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
NCT04811131 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Vitiligo With Low-energy Visible Light Laser
NCT01259986 ·Status: TERMINATED ·Phase: NA
-
Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder
NCT03578315 ·Status: COMPLETED ·Phase: NA
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241 ·Status: COMPLETED ·Phase: NA
-
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
NCT03123016 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
NCT03718962 ·Status: COMPLETED ·Phase: NA
-
Study of Laser Treatment of Melasma
NCT01335581 ·Status: COMPLETED ·Phase: NA
-
Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma
NCT03155698 ·Status: UNKNOWN ·Phase: NA
-
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
NCT05037981 ·Status: COMPLETED
-
T Central Memory Cells in Early Localized Non-Segmental Vitiligo
NCT05706636 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
NCT01923142 ·Status: TERMINATED ·Phase: PHASE2
-
Topical Bimatoprost Solution 0.03%in Stable Vitiligo
NCT01202513 ·Status: WITHDRAWN ·Phase: PHASE4
-
Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study
NCT01956435 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions
NCT03565146 ·Status: COMPLETED ·Phase: NA
-
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
NCT04774809 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224 ·Status: COMPLETED ·Phase: NA
-
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
NCT02191748 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo
NCT02625012 ·Status: UNKNOWN
-
UVA1 Light for Scleroderma and Similar Conditions
NCT00476697 ·Status: TERMINATED ·Phase: NA
-
Topical Ruxolitinib for the Treatment of Vitiligo
NCT02809976 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
NCT03715829 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma
NCT02730819 ·Status: COMPLETED ·Phase: PHASE2
-
Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol
NCT00525395 ·Status: UNKNOWN ·Phase: PHASE3